Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KALA | AMGN | GILD | CELG | VRTX |
| Company | Kala Bio Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 6.32 | 265.72 | 65.50 | 108.01 | 393.52 |
| High | 6.54 | 271.68 | 66.35 | 108.59 | 399.68 |
| Low | 6.24 | 265.72 | 64.63 | 107.27 | 393.49 |
| Last | 6.54 | 270.36 | 65.49 | 108.24 | 398.92 |
| Change | +0.36 | +0.98 | +0.22 | +0.11 | +1.22 |
| % Change | +5.82% | +0.36% | +0.34% | +0.10% | +0.31% |
| Volume | 3,847 | 659,929 | 6,908,579 | 191,230,496 | 246,576 |
| 20-Day Average Volume | 12,399 | 2,064,327 | 6,766,125 | 16,188,930 | 921,171 |
| Previous Close | 6.18 | 269.38 | 65.27 | 108.13 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.09 | 269.99 | 68.30 | 108.17 | 401.38 |
| 20-Day Raw Stochastic | 6.60% | 40.16% | 11.64% | 63.25% | 28.02% |
| 20-Day Relative Strength | 33.76% | 45.50% | 30.43% | 64.69% | 44.36% |
| Weighted Alpha | -59.79 | +9.47 | -23.14 | +46.30 | +15.60 |
| Today's Opinion | 72% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 72% Sell | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 8% Buy | 40% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.70% since 04/19/24 | +0.40% since 04/19/24 | -1.69% since 04/19/24 | -1.97% since 11/13/19 | +1.33% since 04/19/24 |
| Low | 6.15 on 04/22/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 393.00 on 04/25/24 |
| High | 6.77 on 04/25/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -20.30% since 03/26/24 | -4.17% since 03/26/24 | -9.36% since 03/26/24 | +5.14% since 10/18/19 | -4.52% since 03/26/24 |
| Low | 6.15 on 04/22/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 8.12 on 04/02/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -11.80% since 01/26/24 | -13.39% since 01/26/24 | -17.47% since 01/26/24 | +13.63% since 08/20/19 | -7.12% since 01/26/24 |
| Low | 6.15 on 04/22/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 8.23 on 02/22/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -15.02% since 10/26/23 | +0.11% since 10/26/23 | -16.39% since 10/26/23 | +14.14% since 05/20/19 | +10.59% since 10/26/23 |
| Low | 5.10 on 11/14/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 10.97 on 12/05/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,406 | 144,488,960 | 81,266,176 | 77,035,920 | 102,789,152 |
| Shares Outstanding, K | 2,816 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -42,200,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -8,630,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | -1.85 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.18 on 03/29/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 29.82 |